Mechanisms of estrogen receptor-α upregulation in breast cancers

Medical Molecular Morphology

Volumn 43, Issue 4, 2010, Pages 193-196

  Miyoshi, Yasuo ^a   Murase, Keiko ^a   Saito, Masaru ^a   Imamura, Michiko ^a   Oh, Koushi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Breast cancer; Estrogen receptor; Ubiquitin proteasome pathway; Upregulation

Indexed keywords

BRCA1 PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3; KI 67 ANTIGEN; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEASOME; PROTEIN MDM2; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

BREAST CANCER; BREAST CELL; CANCER GROWTH; CELL NUCLEUS; CELL PROLIFERATION; ESTROGEN SYNTHESIS; GENE AMPLIFICATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; UP-REGULATION;

EID: 79952664143     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0514-3     Document Type: Review

References (23)

1. Henry JA, Nicholson S, Farndon JR, Westley BR, May FE (1988) Measurement of oestrogen receptor mRNA levels in human breast tumours. Br J Cancer 58:600-605 (Pubitemid 19010709)
2. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond) 320:134-139 (Pubitemid 16105150)
3. deGraffenried LA, Hilsenbeck SG, Fuqua SA (2002) Sp1 is essential for estrogen receptor alpha gene transcription. J Steroid Biochem Mol Biol 82:7-18
4. Hayashi S, Imai K, Suga K, Kurihara T, Higashi Y, Nakachi K (1997) Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis (Oxf) 18:459-464 (Pubitemid 28132480)
5. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, Sauter G, Simon R (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39:655-660 (Pubitemid 46676104)
6. Brown LA, Hoog J, Chin SF, Tao Y, Zayed AA, Chin K, Teschendorff AE, Quackenbush JF, Marioni JC, Leung S, Perou CM, Neilsen TO, Ellis M, Gray JW, Bernard PS, Huntsman DG, Caldas C (2008) ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 40:806-807
7. Martin MB, Saceda M, Lindsey RK (1993) Regulation of estrogen receptor expression in breast cancer. Adv Exp Med Biol 330:143-153 (Pubitemid 23202998)
8. Lonard DM, Nawaz Z, Smith CL, O'Malley BW (2000) The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 5:939-948
9. Molinari E, Gilman M, Natesan S (1999) Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J 18:6439-6447 (Pubitemid 29533247)
10. Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, Cavaillès V (2007) Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 67:5513-5521 (Pubitemid 46997293)
11. Li L, Li Z, Howley PM, Sacks DB (2006) E6AP and calmodulin reciprocally regulate estrogen receptor stability. J Biol Chem 281:1978-1985 (Pubitemid 43845784)
12. Eakin CM, Maccoss MJ, Finney GL, Klevit RE (2007) Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase. Proc Natl Acad Sci U S A 104:5794-5799 (Pubitemid 47175613)
13. Fan M, Nakshatri H, Nephew KP (2004) Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation. Mol Endocrinol 18:2603-2615 (Pubitemid 39482052)
14. Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D (2007) Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol Endocrinol 21:2427-2439 (Pubitemid 47529356)
15. Hayashi S, Yamaguchi Y (2008) Estrogen signaling pathway and hormonal therapy. Breast Cancer 15:256-261
16. Sisci D, Surmacz E (2007) Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. Curr Pharm Des 13:705-717 (Pubitemid 46510746)
17. Weigel NL, Zhang Y (1998) Ligand-independent activation of steroid hormone receptors. J Mol Med 76:469-479 (Pubitemid 28261256)
18. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991 (Pubitemid 27498105)
19. Tan H, Zhong Y, Pan Z (2009) Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. BMC Cancer 26:31
20. Fabian CJ, Kimler BF, Zalles CM, Khan QJ, Mayo MS, Phillips TA, Simonsen M, Metheny T, Petroff BK (2007) Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. Breast Cancer Res Treat 106:75-84 (Pubitemid 47498093)
21. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH (2005) Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta-1 in adult mice. Am J Pathol 167:409-417 (Pubitemid 43026097)
22. Badve S, Nakshatri H (2009) Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Clin Pathol 62:6-12
23. Harrell JC, Dye WW, Harvell DM, Pinto M, Jedlicka P, Sartorius CA, Horwitz KB (2007) Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis. Cancer Res 67:10582-10591 (Pubitemid 350070835)